Current:Home > NewsFDA authorizes first revamp of COVID vaccines to target omicron -VanguardEdge
FDA authorizes first revamp of COVID vaccines to target omicron
View
Date:2025-04-14 00:12:37
The Food and Drug Administation authorized reformulated versions of the Moderna and Pfizer-BioNTech vaccines that aim to protect against the omicron variant.
The new shots target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now. This double-barreled vaccine is called a bivalent vaccine.
"The FDA has been planning for the possibility that the composition of the COVID-19 vaccines would need to be modified to address circulating variants. ... We have worked closely with the vaccine manufacturers to ensure the development of these updated boosters was done safely and efficiently," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, in an agency statement. "The FDA has extensive experience with strain changes for annual influenza vaccines. We are confident in the evidence supporting these authorizations."
The Moderna COVID-19 vaccine is authorized for use as a single booster dose in people 18 and older. The Pfizer-BioNTech booster is authorized for people 12 years and up. People are eligible for the new boosters two months after completing their initial vaccination or their last booster shot.
The federal government plans to make the boosters available starting next week. In advance of the FDA's decision, Dr. Ashish Jha, the White House COVID-19 Response Coordinator told NPR that the new boosters represented "a really important moment in this pandemic."
Public health officials hope they will help contain a possible fall and winter surge.
But there is also skepticism about how big a difference the boosters can make. "It could be problematic if the public thinks that the new bivalent boosters are a super-strong shield against infection, and hence increased their behavioral risk and exposed themselves to more virus," John Moore, an immunologist at Weill Cornell Medicine in New York, told NPR before the FDA decision.
veryGood! (67)
Related
- Sam Taylor
- Emhoff to announce $1.7B in pledges to help US President Biden meet goal of ending hunger by 2030
- Houston passes Connecticut for No. 1 spot in USA TODAY Sports men's college basketball poll
- How do you get lice? Here's who is most susceptible, and the truth about how it spreads
- Jury finds man guilty of sending 17-year-old son to rob and kill rapper PnB Rock
- 4 charged with transporting Iranian-made weapons face detention hearings in US court
- Leader of Georgia state Senate Democrats won’t seek office again this year
- Monty Williams rips officials after 'worst call of season' costs Detroit Pistons; ref admits fault
- 'Stranger Things' prequel 'The First Shadow' is headed to Broadway
- Her air-ambulance ride wasn't covered by Medicare. It will cost her family $81,739
Ranking
- Romantasy reigns on spicy BookTok: Recommendations from the internet’s favorite genre
- Drake expresses support for Tory Lanez after Megan Thee Stallion shooting
- UAW says a majority of workers at an Alabama Mercedes plant have signed cards supporting the union
- Could Missouri’s ‘stand your ground’ law apply to the Super Bowl celebration shooters?
- Kylie Jenner Shows Off Sweet Notes From Nieces Dream Kardashian & Chicago West
- Peter Morgan, lead singer of reggae siblings act Morgan Heritage, dies at 46
- Kylie Kelce Details Story Behind Front Row Appearance at Milan Fashion Week
- Notable numbers capture the wild weather hitting much of the US this week
Recommendation
NCAA hits former Michigan coach Jim Harbaugh with suspension, show-cause for recruiting violations
Cameo is being used for political propaganda — by tricking the stars involved
Jennifer Aniston forgets the iconic 'Rachel' haircut from 'Friends' in new Uber Eats ad
U.K. companies that tried a 4-day workweek report lasting benefits more than a year on
The Best Stocking Stuffers Under $25
3 dividend stocks that yield more than double the S&P 500
New York City medical school students to receive free tuition moving forward thanks to historic donation
U.K. companies that tried a 4-day workweek report lasting benefits more than a year on